Expression and action of cytokines in the brain: Mechanisms and pathophysiological implications

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 271-280

  Dantzer, Robert ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882544868     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50018-6     Document Type: Chapter

References (89)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
2. Alblas J., Honing H., de Lavalette C.R., Brown M.H., Dijkstra C.D. and van den Berg T.K., 2005 Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/ NAPDH oxidase/H2 pathways, Mol. Cell. Biol., 25:7181-7192.
3. Bajetto A., Bonavia R., Barbero S., Florio T., Schettini G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 2001, 22:147-184.
4. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11:973-984.
5. Bartfai T., Schultzberg M. Cytokines in neuronal cell types. Neurochem. Int. 1993, 22:435-444.
6. Baumann N., Baron-Van Evercooren A., Jacque C., Zalc B. Glial biology and disorders. Curr. Opin. Neurol. Neurosurg. 1993, 6:27-33.
7. Benchenane K., Lopez-Atalaya J.P., Fernandez-Monreal M., Touzani O., Vivien D. Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci. 2004, 27:155-160.
8. Benveniste E.N., Nguyen V.T., O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 2001, 39:381-391.
9. Beraki S., Aronsson F., Karlsson H., Ogren S.O., Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol. Psychiatry 2005, 10:299-308.
10. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
11. Bessis A., Bernard D., Triller A. Tumor necrosis factoralpha and neuronal development. Neuroscientist 2005, 11:277-281.
12. Blond D., Campbell S.J., Butchart A.G., Perry V.H., Anthony D.C. Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain. Brain Res. 2002, 958:89-99.
13. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61:774-780.
14. Buisson A., Lesne S., Docagne F., Ali C., Nicole O., MacKenzie E.T., Vivien D. Transforming growth factor-beta and ischemic brain injury. Cell. Mol. Neurobiol. 2003, 23:539-550.
15. Capuron L., Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun 2003, 17(Suppl 1). S119-124.
16. Chakravarty S., Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005, 25:1788-1796.
17. Cocchiara R., Bongiovanni A., Albeggiani G., Azzolina A., Geraci D. Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor-alpha production. Neuroreport 1998, 9:95-98.
18. Coelho A.M., Fioramonti J., Bueno L. Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G781-G790.
19. Dantzer R., Bluthe R.M., Castanon N., Kelley K.W., Konsman J.P., Laye S., et al. Cytokines, sickness behavior, and depression. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
20. Diana A., Van Dam A.M., Winblad B., Schultzberg M. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and su nuclei of the rat hypothalamus. Neuroscience 1999, 89:137-147.
21. Dinarello C.A. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 2004, 10:201-222.
22. Dinarello C.A., Cannon J.G., Mier J.W., Bernheim H.A., LoPreste G., Lynn D.L., et al. Multiple biological activities of human recombinant interleukin 1. J. Clin. Invest. 1986, 77:1734-1739.
23. Dinarello C.A., Wolff S.M. Molecular basis of fever in humans. Am. J. Med. 1982, 72:799-819.
24. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
25. Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J., Rozemuller J.M., Veerhuis R., Williams A. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002, 40:232-239.
26. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol 2002, 22:25-33.
27. Felton L.M., Perry V.H. The interaction between brain inflammation and systemic infection. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
28. Ferri C.C., Yuill E.A., Ferguson A.V. Interleukin-1beta depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non-sele conductance. Regul. Pept. 2005, 129:63-71.
29. Fogal B., Hewett J.A., Hewett S.J. Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivation. J. Neuroimmunol. 2005, 161:93-100.
30. Fontana A., Weber E., Dayer J.M. Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction?. J. Immunol. 1984, 133:1696-1698.
31. Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 2001, 13:114-119.
32. Goshen I., Yirmiya R. The role of pro-inflammatory cytokines in memory processes and neural plasticity. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
33. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239:290-292.
34. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
35. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:788-789.
36. Hulse R.E., Kunkler P.E., Fedynyshyn J.P., Kraig R.P. Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J. Neurosci. Methods 2004, 136:87-98.
37. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
38. Johnson R.W., Godbout J.P. Aging, neuroinflammation, and behavior. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
39. Kagiwada K., Chida D., Sakatani T., Asano M., Nambu A., Kakuta S., Iwakura Y. Interleukin (IL)-6, but not IL- 1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral. Endocrinology 2004, 145:5044-5048.
40. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
41. Kokovay E., Cunningham L.A. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease. Neurobiol. Dis. 2005, 19:471-478.
42. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
43. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin- 1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by periphe inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
44. Larrick J.W., Wright S.C. Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 1990, 4:3215-3223.
45. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003, 42:139-148.
46. Lazarus M., Saper C.B. The differential role of prostaglandin E2 receptors in the response to systemic immune challenge. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
47. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115:71-83.
48. Leonard B.E. The immune system, depression and the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:767-780.
49. Li S., Goorha S., Ballou L.R., Blatteis C.M. Intracerebroventricular interleukin-6, macrophage inflammatory protein- 1 beta and IL-18, pyrogenic and PGE(2)-mediated?. Brain Res. 2003, 992:76-84.
50. Li W., Galey D., Mattson M.P., Nath A. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox. Res. 2005, 8:119-134.
51. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., Thompson C.B. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
52. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 1999, 461:25-46.
53. Matsumura K., Kobayashi S. Signaling the brain in inflammation: the role of endothelial cells. Front. Biosci. 2004, 9:2819-2826.
54. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005, 30:883-893.
55. McColl B.W., Stock C.J., Rothwell N.J. Cytokines and non-immune brain injury. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
56. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV associated dementia, Alzheimer disease, and multiple sc. J. Neurol. Sci. 2002, 202:13-23.
57. Minghetti L., Ajmone-Cat M.A., De Berardinis M.A., DeSimone R. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res. Brain Res. Rev. 2005, 48:251-256.
58. Mo Z.L., Katafuchi T., Hori T. Effects of IL-1 beta on neuronal activities in the dorsal motor nucleus of the vagus in rat brain slices. Brain Res. Bull. 1996, 41:249-255.
59. Moller A., Henz B.M., Grutzkau A., Lippert U., Aragane Y., Schwarz T., Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998, 93:289-295.
60. Murray C.A., Lynch M.A. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term pot. J. Neurosci 1998, 18:2974-2981.
61. Nadjar A., Bluthe R.M., May M.J., Dantzer R., Parnet P. Inactivation of the cerebral NFkappaB pathway inhibits interleukin- 1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 2005, 30:1492-1499.
62. Nadjar A., Combe C., Busquet P., Dantzer R., Parnet P. Signaling pathways of interleukin-1 actions in the brain: anatomical distribution of phospho-ERK1/2 in the brain of rat treated systemically with interleukin-. Neuroscience 2005, 134:921-932.
63. Nadjar A., Tridon V., May M.J., Ghosh S., Dantzer R., Amedee T., Parnet P. NFkappaB activates in vivo the synthesis of inducible COX-2 in the brain. J. Cereb. Blood Flow Metab. 2005, 25:1047-1059.
64. Nakashima K., Taga T. Mechanisms underlying cytokine- mediated cell-fate regulation in the nervous system. Mol. Neurobiol. 2002, 25:233-244.
65. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
66. O'Neill L.A., Dunne A., Edjeback M., Gray P., Jefferies C., Wietek C. Mal and MyD88, adapter proteins involved in signal transduction by Toll-like receptors. J. Endotoxin. Res. 2003, 9:55-59.
67. Parnet P., Kelley K.W., Bluthe R.M., Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J. Neuroimmunol. 2002, 125:5-14.
68. Pavlov V.A., Tracey K.J. The cholinergic antiinflammatory pathway. Brain Behav. Immun. 2005, 19:493-499.
69. Perry V.H., Andersson P.B. The inflammatory response in the CNS. Neuropathol. Appl. Neurobiol. 1992, 18:454-459.
70. Ravizza T., Vezzani A. Status epilepticus induces timedependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 2006, 137:301-308.
71. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
72. Roth K.A., D'Sa C. Apoptosis and brain development. Ment. Retard. Dev. Disabil. Res. Rev. 2001, 7:261-266.
73. Sang N., Zhang J., Marcheselli V., Bazan N.G., Chen C. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci. 2005, 25:9858-9870.
74. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7778-7783.
75. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
76. Shishodia S., Aggarwal B.B. Nuclear factor-kappaB activation: a question of life or death. J. Biochem. Mol. Biol. 2002, 35:28-40.
77. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315.
78. Simard A.R., Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 2004, 18:998-1000..
79. Stirling D.P., Koochesfahani K.M., Steeves J.D., Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005, 11:308-322.
80. Tabarean I.V., Behrens M.M., Bartfai T., Korn H. Prostaglandin E2-increased thermosensitivity of anterior hypothalamic neurons is associated with depressed inhibition. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2590-2595.
81. Tazi A., Dantzer R., Crestani F., Le Moal M. Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity. Brain Res. 1988, 473:369-371.
82. Tocco-Bradley R., Moldawer L.L., Jones C.T., Gerson B., Blackburn G.L., Bistrian B.R. The biological activity in vivo of recombinant murine interleukin 1 in the rat. Proc. Soc. Exp. Biol. Med. 1986, 182:263-271.
83. Touzani O., Boutin H., LeFeuvre R., Parker L., Miller A., Luheshi G., Rothwell N. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J. Neurosci. 2002, 22:38-43.
84. Tracey K.J. Fat meets the cholinergic antiinflammatory pathway. J. Exp. Med. 2005, 202:1017-1021.
85. Vallieres L., Rivest S. Interleukin-6 is a needed proin-flammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during. Endocrinology 1999, 140:3890-3903.
86. Wajant H. Death receptors. Essays Biochem. 2003, 39:53-71.
87. Watkins L.R., Wieseler-Frank J., Hutchinson M.R., Ledeboer A., Spataro L., Milligan E.D., et al. Neuroimmune interactions and pain: the role of immune and glial cells. Psychoneuroimmunology 2006, Elsevier, San Diego. 4th ed. R. Ader (Ed.).
88. Wichers M.C., Koek G.H., Robaeys G., Verkerk R., Scharpe S., Mae M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 2005, 10:538-544.
89. Zink M.C., Uhrlaub J., DeWitt J., Voelker T., Bullock B., Mankowski J., et al. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005, 293:2003-2011.